Yayınlar

1: Yazici H, Ugurlu S, Seyahi E. Behçet syndrome: is it one condition? Clin Rev Allergy Immunol. 2012 Dec;43(3):275-80.

2: Yazici H, Fresko I. Behçet's disease and other autoinflammatory conditions: what's in a name? Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S1-2.

3: Celik S, Yazici Y, Yazici H. Are sample sizes of randomized clinical trials in rheumatoid arthritis too large? Eur J Clin Invest. 2014 Sep 10.

4: Frank-Bertoncelj M, Hatemi G, Ospelt C, Ramiro S, Machado P, Mandl P, Gossec L, Buch MH. Mentoring of young professionals in the field of rheumatology in Europe: results from an EMerging EUlar NETwork (EMEUNET) survey. Clin Exp Rheumatol. 2014 Sep 8.

5: Yazici H. Methotrexate and not much harm to the lungs. Clin Exp Rheumatol. 2014 Aug 26.

6: Yazici H. A personal account of the evidence for evidence-based medicine. Bull Hosp Jt Dis (2013). 2014;72(2):133-5.  

7: Oyur KB, Engin B, Hatemi G, Asma A, Kutlubay Z, Bulut N, Serdaroğlu S, Tüzün Y. Turkish PASE: Turkish Version of the Psoriatic Arthritis Screening and Evaluation Questionnaire. Ann Dermatol. 2014 Aug;26(4):457-61.

8: Saygin C, Uzunaslan D, Ugurlu S. Antineutrophil cytoplasmic antibody-associated neutropenia in a patient with type 1 diabetes mellitus. Lab Hematol. 2014 Jun;20(2):7-8.

9: Direskeneli H, Akkoç N, Bes C, Cakir N, Cefle A, Cobankara V, Dalkilic E, Dinc A, Ertenli I, Gul A, Hamuryudan V, Inanc M, Kalyoncu U, Karaaslan Y, Kasifoglu T, Keser G, Keskin G, Kisacik B, Kiraz S, Masatlioglu S, Onat AM, Ozbek S, Ozturk MA, Pamuk ON, Pay S, Pirildar T, Sayarlioglu M, Senel S, Senturk T, Tasan D, Terzioglu E, Yazici A, Yucel E. Impact of rheumatoid arthritis in Turkey: a questionnaire study. Clin Exp Rheumatol. 2014 Jul-Aug;32(4):477-83.

10: Sibley C, Yazici Y, Tascilar K, Khan N, Bata Y, Yazici H, Goldbach-Mansky R, Hatemi G. Behçet syndrome manifestations and activity in the United States versus Turkey -- a cross-sectional cohort comparison. J Rheumatol. 2014 Jul;41(7):1379-84.

11: Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014 Jun 6.

12: Ozyazgan Y, Ucar D, Hatemi G, Yazici Y. Ocular Involvement of Behçet's Syndrome: a Comprehensive Review. Clin Rev Allergy Immunol. 2014 May 15.

13: Yurdakul S, Mustafa BN, Fresko I, Seyahi E, Yazici H. Brief report: inadequate description and discussion of enrolled patient characteristics and potential inter-study site differences in reports of randomized controlled trials: a systematic survey in six rheumatology journals. Arthritis Rheumatol. 2014 May;66(5):1395-9.

14: Mat MC, Sevim A, Fresko I, Tüzün Y. Behçet's disease as a systemic disease. Clin Dermatol. 2014 May-Jun;32(3):435-42.

15: Ozguler Y, Hatemi G, Yazici H. Management of Behçet's syndrome. Curr Opin Rheumatol. 2014 May;26(3):285-91.

16: Soysal T, Salihoğlu A, Esatoğlu SN, Gültürk E, Eşkazan AE, Hatemi G, Hatemi I, Öngören Aydın Ş, Erzin YZ, Başlar Z, Tüzüner N, Ferhanoğlu B, Çelik AF. Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature. Rheumatology (Oxford). 2014 Jun;53(6):1136-41.

17: Hamuryudan V, Hatemi G, Tascilar K, Yurdakul S, Mat C, Ozyazgan Y, Seyahi E,
Ugurlu S, Yazici H. Colchicine in Behçet syndrome: a longterm survey of patients in a controlled trial. J Rheumatol. 2014 Apr;41(4):735-8.

18: Hatemi G, Merkel PA, Hamuryudan V, Boers M, Direskeneli H, Aydin SZ, Yazici
H. Outcome measures used in clinical trials for Behçet syndrome: a systematic review. J Rheumatol. 2014 Mar;41(3):599-612.

19: Yazici H, Yazici Y. Criteria for Behçet's disease with reflections on all disease criteria. J Autoimmun. 2014 Feb-Mar;48-49:104-7.

20: Yazici H, Gogus F, Esen F, Yazici Y. There was less self-critique among basic than in clinical science articles in three rheumatology journals. J Clin Epidemiol. 2014 Jun;67(6):654-7.

21: Merkel PA, Aydin SZ, Boers M, Cornell C, Direskeneli H, Gebhart D, Hatemi G, Luqmani R, Matteson EL, Milman N, Robson J, Seo P, Tomasson G. Current status of outcome measure development in vasculitis. J Rheumatol. 2014 Mar;41(3):593-8.

22: Yurdakul S, Mustafa BN, Fresko I, Seyahi E, Yazici H. Inadequate description and discussion of enrolled patient characteristics and Potential inter-study site differences in reports of randomized controlled trials: A systematic survey in 6 rheumatology journals. Arthritis Rheum. 2014 Jan 8.

23: Uzunaslan D, Saygin C, Hatemi G, Tascilar K, Yazici H. No appreciable decrease in fertility in Behçet's syndrome. Rheumatology (Oxford). 2014 May;53(5):828-33.

24: Hatemi G, Yazici H. Tuberculosis screening before and during treatment with tumor necrosis factor antagonists: something old, something new. J Rheumatol. 2013 Dec;40(12):1938-40.

25: Hatemi G, Seyahi E, Fresko I, Hamuryudan V. Behçet's syndrome: a critical digest of the 2012-2013 literature. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):108-17.

26: Ozyazgan S, Uzun H, Onal B, Tuzcu A, Ugurlu S, Andican G. Lectin-like oxidised LDL receptor-1 as a marker of endothelial dysfunction in Behçet's disease. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):71-6.

27: La Regina M, Ben-Chetrit E, Gasparyan AY, Livneh A, Ozdogan H, Manna R. Current trends in colchicine treatment in familial Mediterranean fever. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):41-6.

28: Yüksel Ş, Eren E, Hatemi G, Sahillioğlu AC, Gültekin Y, Demiröz D, Akdiş C, Fresko İ, Özören N. Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behçet's syndrome patients. Int Immunol. 2014 Feb;26(2):71-81.

29: Yazici H. The urge to prove and its ills. Bull Hosp Jt Dis (2013). 2013;71(2):121-3.

30: Yetkin DO, Celik O, Hatemi G, Kadioglu P. Sexual dysfunction and depression in premenopausal women with mucocutaneous Behçet's disease. Int J Rheum Dis. 2013 Aug;16(4):463-8.

31: Seyahi E, Yazici H. Pregnancy and Behçet's disease: comment on the article by Noel et al. Arthritis Rheum. 2013 Nov;65(11):3007.

32: Saruhan-Direskeneli G, Hughes T, Aksu K, Keser G, Coit P, Aydin SZ, Alibaz-Oner F, Kamalı S, Inanc M, Carette S, Hoffman GS, Akar S, Onen F, Akkoc N, Khalidi NA, Koening C, Karadag O, Kiraz S, Langford CA, McAlear CA, Ozbalkan Z, Ates A, Karaaslan Y, Maksimowicz-McKinnon K, Monach PA, Ozer HT, Seyahi E, Fresko I, Cefle A, Seo P, Warrington KJ, Ozturk MA, Ytterberg SR, Cobankara V, Onat AM, Guthridge JM, James JA, Tunc E, Duzgun N, Bıcakcıgil M, Yentür SP, Merkel PA, Direskeneli H, Sawalha AH. Identification of multiple genetic susceptibility loci in Takayasu arteritis. Am J Hum Genet. 2013 Aug 8;93(2):298-305.

33: Mat C, Yurdakul S, Sevim A, Özyazgan Y, Tüzün Y. Behçet's syndrome: facts and
controversies. Clin Dermatol. 2013 Jul-Aug;31(4):352-61.

34: Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Ugurlu S, Erer B, Abaci N, Ustek D, Meguro A, Ueda A, Takeno M, Inoko H, Ombrello MJ, Satorius CL, Maskeri B, Mullikin JC, Sun HW, Gutierrez-Cruz G, Kim Y, Wilson AF, Kastner DL, Gül A, Remmers EF. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet disease. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8134-9.

35: Hatemi G, Yazici Y, Yazici H. Behçet's syndrome. Rheum Dis Clin North Am. 2013 May;39(2):245-61. doi: 10.1016/j.rdc.2013.02.010.

36: Diamantopoulos AP, Hatemi G. Lack of efficacy of tocilizumab in mucocutaneous
Behcet's syndrome: report of two cases. Rheumatology (Oxford). 2013;52(10):1923-4.

37: Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, Klearman M, Musselman D, Agarwal S, Green J, Kavanaugh A; ADACTA Study Investigators. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial. Lancet. 2013 May 4;381(9877):1541-50.

38: Yazici H, Tascilar K, Yazici Y. Neoplasms as the leading cause of death among
patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et al. Arthritis Rheum. 2013 Jun;65(6):1670.

39: Ozen S, Demirkaya E, Amaryan G, Koné-Paut I, Polat A, Woo P, Uziel Y, Modesto C, Finetti M, Quartier P, Papadopoulou-Alataki E, Al-Mayouf SM, Fabio G, Gallizzi R, Cantarini L, Frenkel J, Nielsen S, Hofer M, Insalaco A, Acikel C, Ozdogan H, Martini A, Ruperto N, Gattorno M; Paediatric Rheumatology International Trials Organisation; Eurofever Project. Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in children. Ann Rheum Dis. 2014 Apr;73(4):662-7.

40: Seyahi E, Ucgul A, Cebi Olgun D, Ugurlu S, Akman C, Tutar O, Yurdakul S, Yazici H. Aortic and coronary calcifications in Takayasu arteritis. Semin Arthritis Rheum. 2013 Aug;43(1):96-104.

41: Berkun Y, Wason S, Brik R, Butbul Y, Ben-Chetrit E, Hashkes PJ, Livneh A, Ozen S, Ozdogan H, Faulkner R, Davis MW. Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever. Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):1121-30.

42: Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, Kastner DL. Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013 Feb;45(2):202-7.

43: Sarkis C, Caglar E, Ugurlu S, Cetinkaya E, Tekin N, Arslan M, Ozdemir S, Tuncer M. Nonalcoholic fatty liver disease and familial Mediterranean fever: are they related? Srp Arh Celok Lek. 2012 Sep-Oct;140(9-10):589-94.

44: Ruperto N, Brunner HI, Quartier P, Constantin T, Wulffraat N, Horneff G, Brik R, McCann L, Kasapcopur O, Rutkowska-Sak L, Schneider R, Berkun Y, Calvo I, Erguven M, Goffin L, Hofer M, Kallinich T, Oliveira SK, Uziel Y, Viola S, Nistala K, Wouters C, Cimaz R, Ferrandiz MA, Flato B, Gamir ML, Kone-Paut I, Grom A, Magnusson B, Ozen S, Sztajnbok F, Lheritier K, Abrams K, Kim D, Martini A, Lovell DJ; PRINTO; PRCSG. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012 Dec 20;367(25):2396-406.

45: Yalin AS, Altiparmak MR, Trabulus S, Yalin SF, Yalin GY, Melikoglu M. Calciphylaxis: a report of six cases and review of literature. Ren Fail. 2013;35(1):163-9.

46: Hatemi G, Seyahi E, Fresko I, Hamuryudan V. Behçet's syndrome: a critical digest of the recent literature. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S80-9.

47: Yazici H, Hatemi G. Empiricism in managing Behçet's syndrome. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S7-9.

48: Fresko I. 15th International Congress on Behçet's Disease. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S118-28.

49: Hamuryudan V, Hatemi G, Sut N, Ugurlu S, Yurdakul S, Yazici H. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S32-4.

50: Yazici H. Beware of registries for their biases. Bull NYU Hosp Jt Dis. 2012;70(2):95-8.

51: Turkstra F, van Vugt RM, Dijkmans BA, Yazici Y, Yazici H. Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment. Clin Exp Rheumatol. 2012 May-Jun;30(3 Suppl 72):S10-3.

52: Hatemi G, Melikoglu M, Ozbakir F, Tascilar K, Yazici H. Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists. Arthritis Res Ther. 2012 Jun 18;14(3):R147.

53: Tayer-Shifman OE, Seyahi E, Nowatzky J, Ben-Chetrit E. Major vessel thrombosis in Behçet's disease: the dilemma of anticoagulant therapy – the approach of rheumatologists from different countries. Clin Exp Rheumatol. 2012 Sep-Oct;30(5):735-40.

54: Gaujoux-Viala C, Knevel R, Mandl P, Nagy G, Frank M, Machado P, Hatemi G, Buch MH, Aletaha D, Gossec L; EMEUNET working group. Who are the young professionals working in the field of rheumatology in Europe and what are their needs? An EMEUNET (EMerging EUlar NETwork) survey. Ann Rheum Dis. 2012 Aug;71(8):1432-3.

55: Ugurlu S, Ucar D, Seyahi E, Hatemi G, Yurdakul S. Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease. Ann Rheum Dis. 2012 Sep;71(9):1589-91.

56: Yazici H, Yazici Y. Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al. Arthritis Rheum. 2012 Jul;64(7):2414; author reply 2414-5.

57: Malhan S, Pay S, Ataman S, Dalkilic E, Dinc A, Erken E, Ertenli I, Ertugrul E, Gogus F, Hamuryudan V, Inanc M, Karaarslan Y, Karadag O, Karakoc Y, Keskin G, Kisacik B, Kiraz S, Oksel F, Oksuz E, Pirildar T, Sari I, Soy M, Senturk T, Taylan A. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey. Clin Exp Rheumatol. 2012 Mar-Apr;30(2):202-7.

58: Büyüktas D, Hatemi G, Tascilar K, Fresko I, Yurdakul S. Should immunosuppressives be stopped in granulomatosis with polyangiitis (Wegener's granulomatosis) patients undergoing dialysis? Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S104-6.

59: Sahin Z, Bıcakcıgil M, Aksu K, Kamali S, Akar S, Onen F, Karadag O, Ozbalkan Z, Ates A, Ozer HT, Yilmaz V, Seyahi E, Ozturk MA, Cefle A, Cobankara V, Onat AM, Tunc E, Düzgün N, Aydin SZ, Yilmaz N, Fresko İ, Karaaslan Y, Kiraz S, Akkoc N, Inanc M, Keser G, Uyar FA, Direskeneli H, Saruhan-Direskeneli G; Turkish Takayasu Study Group. Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey. Arthritis Res Ther. 2012 Feb 6;14(1):R27.

60: Karaca M, Hatemi G, Sut N, Yazici H. The papulopustular lesion/arthritis cluster of Behçet's syndrome also clusters in families. Rheumatology (Oxford). 2012 Jun;51(6):1053-60.

61: Direskeneli H, Tuna-Erdoğan E, Gündüz F, Bandurska-Luque A, Alparslan B, Kebe M, Uyar FA, Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Akar S, Önen F, Seyahi E, Onat AM, Aydin SZ, Yilmaz N, Cefle A, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yücel AE, Kiraz S, Keser G, Inanc M, Saruhan-Direskeneli G. PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S11-4.

62: Seyahi E, Melikoglu M, Akman C, Hamuryudan V, Ozer H, Hatemi G, Yurdakul S, Tuzun H, Oz B, Yazici H. Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore). 2012 Jan;91(1):35-48.

63: Yönal O, Hatemi G, Hamzaoğlu Ö. Do anti-TNF agents and combination treatment
increase postoperative complication risk? Turk J Gastroenterol. 2012;23 Suppl 2:25-9.

64: Yönal O, Hatemi G, Kaymakoğlu S. Should maintenance therapy be performed in
ulcerative proctitis? How long should it be continued? Turk J Gastroenterol. 2012;23 Suppl 2:21-4.

65: Ar MC, Hatemi G, Ekizoğlu S, Bilgen H, Saçli S, Buyru AN, Soysal T, Ülkü B, Yazici H. JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome. Clin Appl Thromb Hemost. 2012 Jul;18(4):421-6.

66: Ügurlu U, Özdogan H. Age- and gender-specific normative data of pinch strengths in a healthy Turkish population. J Hand Surg Eur Vol. 2012 Jun;37(5):436-46.

67: Hatemi G, Yazici H. Behçet's syndrome and micro-organisms. Best Pract Res Clin Rheumatol. 2011 Jun;25(3):389-406.

68: Uluduz D, Kürtüncü M, Yapıcı Z, Seyahi E, Kasapçopur Ö, Özdoğan H, Saip S, Akman-Demir G, Siva A. Clinical characteristics of pediatric-onset neuro-Behçet disease. Neurology. 2011 Nov 22;77(21):1900-5.

69: Masatlioglu S, Dulundu E, Gogus F, Hatemi G, Ozdogan H. The frequency of familial Mediterranean fever in an emergency unit. Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S44-6.

70: Yazici H. A critical look at diagnostic criteria: time for a change? Bull NYU Hosp Jt Dis. 2011;69(2):101-3.

71: Guzel S, Andican G, Seven A, Aslan M, Bolayirli M, Guzel EC, Hamuryudan V. Acute phase response and oxidative stress status in familial Mediterranean fever (FMF). Mod Rheumatol. 2012 Jun;22(3):431-7.

72: Tuzun H, Seyahi E, Arslan C, Hamuryudan V, Besirli K, Yazici H. Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease. J Vasc Surg. 2012 Jan;55(1):157-63.

73: Seyahi E, Yurdakul S. Behçet's Syndrome and Thrombosis. Mediterr J Hematol Infect Dis. 2011;3(1):e2011026.

74: Seyahi E, Baskurt M, Melikoglu M, Akman C, Olgun DC, Simsek E, Hamuryudan V,
Kucukoglu S, Yazici H. The estimated pulmonary artery pressure can be elevated in Behçet's syndrome. Respir Med. 2011 Nov;105(11):1739-47.

75: Kirectepe AK, Kasapcopur O, Arisoy N, Celikyapi Erdem G, Hatemi G, Ozdogan H,
Tahir Turanli E. Analysis of MEFV exon methylation and expression patterns in familial Mediterranean fever. BMC Med Genet. 2011 Aug 7;12:105.

76: Haraoui B, Smolen JS, Aletaha D, Breedveld FC, Burmester G, Codreanu C, Da Silva JP, de Wit M, Dougados M, Durez P, Emery P, Fonseca JE, Gibofsky A, Gomez-Reino J, Graninger W, Hamuryudan V, Jannaut Peña MJ, Kalden J, Kvien TK, Laurindo I, Martin-Mola E, Montecucco C, Santos Moreno P, Pavelka K, Poor G, Cardiel MH, Stanislawska-Biernat E, Takeuchi T, van der Heijde D; Treat to Target Taskforce. Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaire. Ann Rheum Dis. 2011 Nov;70(11):1999-2002.

77: Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group;
Paediatric Rheumatology International Trials Organisation. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011 Jul;63(7):929-36.

78: Hasija R, Pistorio A, Ravelli A, Demirkaya E, Khubchandani R, Guseinova D, Malattia C, Canhao H, Harel L, Foell D, Wouters C, De Cunto C, Huemer C, Kimura Y, Mangge H, Minetti C, Nordal EB, Philippet P, Garozzo R, Martini A, Ruperto N; Pediatric Rheumatology International Trials Organization. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum. 2011 Oct;63(10):3142-52.

79: Kirectepe AK, Erdem GC, Senturk N, Arisoy N, Hatemi G, Ozdogan H, Kasapcopur
O, Tahir Turanli E. Increased expression of exon 2 deleted MEFV transcript in
familial Mediterranean fever patients. Int J Immunogenet. 2011 Aug;38(4):327-9.

80: Ozbakir F, Ugurlu S, Celik AF, Seyahi E. Anti-Saccharomyces cerevisiae (ASCA)
and anti-neutrophil cytoplasmic (ANCA) antibodies are not increased in Takayasu
arteritis. Acta Reumatol Port. 2011 Jan-Mar;36(1):20-3.

81: Yucel IK, Seyahi E, Kasapcopur O, Arisoy N. Economic impact of juvenile
idiopathic arthritis and familial Mediterranean fever. Rheumatol Int. 2012
Jul;32(7):1955-62.

82: Tetik S, Ahmad S, Alturfan AA, Fresko I, Disbudak M, Sahin Y, Aksoy H,
Yardimci KT. Determination of oxidant stress in plasma of rheumatoid arthritis
and primary osteoarthritis patients. Indian J Biochem Biophys. 2010
Dec;47(6):353-8.

83: Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, Erguven M,
Poyrazoglu H, Kasapcopur O, Gok F, Akman S, Balat A, Cavkaytar O, Kaya B, Duzova
A, Ozaltin F, Topaloglu R, Besbas N, Bakkaloglu A, Arisoy N, Ozdogan H,
Bakkaloglu S, Turker T. The distribution of juvenile idiopathic arthritis in the
eastern Mediterranean: results from the registry of the Turkish Paediatric
Rheumatology Association. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):111-6.

84: Celik S, Fresko I, Sut N, Batumlu NM, Yazici H, Yazici Y. Differences in pain
and fatigue perception among a group of rheumatoid arthritis patients in the
United States and in Turkey who have similar disease activity and functional
status. Clin Exp Rheumatol. 2010 Nov-Dec;28(6):884-7.

85: Talarico R, Marconcini L, Ben-Chetrit E, Yazici H. Behçet's disease and other
autoinflammatory conditions: a brief account of a decade. Clin Exp Rheumatol.
2010 Jul-Aug;28(4 Suppl 60):S6-8.

86: Masatlioglu S, Seyahi E, Tahir Turanli E, Fresko I, Gogus F, Senates E, Oguz
Savran F, Yazici H. A twin study in Behçet's syndrome. Clin Exp Rheumatol. 2010
Jul-Aug;28(4 Suppl 60):S62-6.

87: Seyahi E, Tahir Turanli E, Mangan MS, Celikyapi G, Oktay V, Cevirgen D,
Kuzuoglu D, Ozoglu S, Yazici H. The prevalence of Behçet's syndrome, familial
Mediterranean fever, HLA-B51 and MEFV gene mutations among ethnic Armenians
living in Istanbul, Turkey. Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl
60):S67-75.

88: Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet's
disease: an update. Curr Opin Rheumatol. 2011 Jan;23(1):24-31.

89: Koné-Paut I, Darce-Bello M, Shahram F, Gattorno M, Cimaz R, Ozen S, Cantarini
L, Tugal-Tutktun I, Assaad-Khalil S, Hofer M, Kuemmerle-Deschner J, Benamour S,
Al Mayouf S, Pajot C, Anton J, Faye A, Bono W, Nielsen S, Letierce A, Tran TA;
PED-BD International Expert Committee. Registries in rheumatological and
musculoskeletal conditions. Paediatric Behçet's disease: an international cohort
study of 110 patients. One-year follow-up data. Rheumatology (Oxford). 2011
Jan;50(1):184-8.

90: Esen F, Schimmel EK, Yazici H, Yazici Y. An audit of Behcet's syndrome
research: a 10-year survey. J Rheumatol. 2011 Jan;38(1):99-103.

91: Yazici Y, Yurdakul S, Yazici H. Behçet's syndrome. Curr Rheumatol Rep. 2010
Dec;12(6):429-35.

92: Yazici H. Thought barriers to understanding rheumatic diseases--Halstead R.
Holman revisited. Bull NYU Hosp Jt Dis. 2010;68(2):143-6.

93: Vilca I, Munitis PG, Pistorio A, Ravelli A, Buoncompagni A, Bica B, Campos L,
Häfner R, Hofer M, Ozen S, Huemer C, Bae SC, Sztajnbok F, Arguedas O, Foeldvari
I, Huppertz HI, Gamir ML, Magnusson B, Dressler F, Uziel Y, van Rossum MA,
Hollingworth P, Cawkwell G, Martini A, Ruperto N; Pediatric Rheumatology
International Trials Organisation (PRINTO). Predictors of poor response to
methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of
the PRINTO methotrexate trial. Ann Rheum Dis. 2010 Aug;69(8):1479-83.

94: Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L,
Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, de Groot K, Guillevin L,
Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CG, Kobayashi S, Little MA,
Mahr A, McLaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani
C, Savage C, Scott DG, Segelmark M, Specks U, Sunderköetter C, Suzuki K, Tesar V,
Wiik A, Yazici H, Luqmani R. EULAR points to consider in the development of
classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis.
2010 Oct;69(10):1744-50.

95: Gossec L, Bijlsma JW, Bombardier C, Canhão H, Devlin J, Edwards CJ,
Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U,
Ostergaard M, Pereira IA, Ramos-Remus C, Zochling J, Dougados M. Dissemination
and evaluation of the 3E initiative recommendations for use of methotrexate in
rheumatic disorders: results of a study among 2233 rheumatologists. Ann Rheum
Dis. 2011 Feb;70(2):388-9.

96: Engin A, Ugurlu S, Caglar E, Oztop AY, Inan D, Elaldi N, Dokmetas I, Bakir M.
Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic
fever. Vector Borne Zoonotic Dis. 2010 Dec;10(10):1037-41.

97: Ateş O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarıkaya A. Analyses of
functional IL10 and TNF-α genotypes in Behçet's syndrome. Mol Biol Rep. 2010
Oct;37(7):3637-41.

98: Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT,
Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc
E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yücel AE, Kiraz S, Keser G, Inanc
M, Direskeneli H. Takayasu's arteritis in Turkey - clinical and angiographic
features of 248 patients. Clin Exp Rheumatol. 2009 Jan-Feb;27(1 Suppl 52):S59-64.

99: Kötter I, Hamuryudan V, Oztürk ZE, Yazici H. Interferon therapy in rheumatic
diseases: state-of-the-art 2010. Curr Opin Rheumatol. 2010 May;22(3):278-83.

100: Hatemi G, Fresko I, Yurdakul S, Ozdogan H, Yazici H, Altiok E, Yenmis G.
Reply to letter by Priori et al commenting on whether Behçet's syndrome patients
with acne and arthritis comprise a true subset. Arthritis Rheum. 2010
Jan;62(1):305-6.

101: Caglar E, Ugurlu S, Ozenoglu A, Can G, Kadioglu P, Dobrucali A. Autoantibody
frequency in celiac disease. Clinics (Sao Paulo). 2009;64(12):1195-200.

102: Hamuryudan V, Hatemi G, Tascilar K, Sut N, Ozyazgan Y, Seyahi E, Mat C,
Yurdakul S, Yazici H. Prognosis of Behcet's syndrome among men with mucocutaneous
involvement at disease onset: long-term outcome of patients enrolled in a
controlled trial. Rheumatology (Oxford). 2010 Jan;49(1):173-7.

103: Esen F, Celik A, Yazici H. The use of diseased control groups in genetic
association studies. Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S4-5.

104: Yazici Y, Yazici H. Comment on: Web resources for rare auto-inflammatory
diseases: towards a common patient registry. Rheumatology (Oxford). 2010
Jan;49(1):198; author reply 198-9.

105: Kiliç H, Zeytin HE, Korkmaz C, Mat C, Gül A, Coşan F, Dinç A, Simşek I, Süt
N, Yazici H. Low-dose natural human interferon-alpha lozenges in the treatment of
Behçet's syndrome. Rheumatology (Oxford). 2009 Nov;48(11):1388-91.

106: Yazici H. Diagnostic versus classification criteria - a continuum. Bull NYU
Hosp Jt Dis. 2009;67(2):206-8.

107: Ugurlu S, Seyahi E, Cetinkaya F, Ozbakir F, Balci H, Ozdogan H. Intima-media
thickening in patients with familial Mediterranean fever. Rheumatology (Oxford).
2009 Aug;48(8):911-5.

108: Turanli ET, Beger T, Erdincler D, Curgunlu A, Karaman S, Karaca E, Dasdemir
S, Bolayirli M, Yazici H. Common MEFV mutations and polymorphisms in an elderly
population: an association with E148Q polymorphism and rheumatoid factor levels.
Clin Exp Rheumatol. 2009 Mar-Apr;27(2):340-3.

109: Ugurlu S, Bolayir E, Candan F, Gumus C. Familial mediterranean fever and
multiple sclerosis--a case report. Acta Reumatol Port. 2009 Jan-Mar;34(1):117-9.

110: Yazici H, Esen F. Mortality in Behçet's syndrome. Clin Exp Rheumatol. 2008
Sep-Oct;26(5 Suppl 51):S138-40. Review.

111: Ates O, Dalyan L, Müsellim B, Hatemi G, Türker H, Ongen G, Hamuryudan V,
Topal-Sarikaya A. NRAMP1 (SLC11A1) gene polymorphisms that correlate with
autoimmune versus infectious disease susceptibility in tuberculosis and
rheumatoid arthritis. Int J Immunogenet. 2009 Feb;36(1):15-9.

112: Ustek D, Ekmekçi C, Oku B, Coşan F, Cakiris A, Abaci N, Celik S, Kamali S,
Hatemi G, Kasapçopur O, Ozdoğan H, Gül A. MEFV gene 3'-UTR Alu repeat
polymorphisms in patients with familial Mediterranean fever. Clin Exp Rheumatol.
2008 Jul-Aug;26(4 Suppl 50):S72-6.

113: Fresko I, Yazici H. Treatment strategies for Behçet's disease. Expert Opin
Pharmacother. 2008 Dec;9(18):3211-9.

114: Yazici H, Seyahi E, Yurdakul S. Behçet's syndrome is not so rare: why do we
need to know? Arthritis Rheum. 2008 Dec;58(12):3640-3.

115: Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J,
Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H,
Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H,
Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G,
Zochling J, Dougados M. Multinational evidence-based recommendations for the use
of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis:
integrating systematic literature research and expert opinion of a broad
international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2009
Jul;68(7):1086-93.

116: Yurdakul S, Yazici H. Behçet's syndrome. Best Pract Res Clin Rheumatol. 2008
Oct;22(5):793-809.

117: Salihoglu A, Seyahi E, Celik S, Yurdakul S. Relapsing polychondritis in a
patient with familial Mediterranean fever and amyloidosis. Clin Exp Rheumatol.
2008 Jul-Aug;26(4 Suppl 50):S125.

118: Oran M, Hatemi G, Tasli L, Garip F, Kadioglu P, Mat C, Yazici H. Behçet's
syndrome is not associated with vitiligo. Clin Exp Rheumatol. 2008 Jul-Aug;26(4
Suppl 50):S107-9.

119: Storz K, Löffler J, Koch S, Vonthein R, Zouboulis CC, Fresko I, Yazici H,
Kötter I. IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are
not associated with Behçet's disease in patients of German or Turkish origin.
Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl 50):S103-6.

120: Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C, Ozyazgan Y,
Yazici H. Frequency of pathergy phenomenon and other features of Behçet's
syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol. 2008
Jul-Aug;26(4 Suppl 50):S91-5.

121: Ben-Chetrit E, Ozdogan H. Non-response to colchicine in FMF--definition,
causes and suggested solutions. Clin Exp Rheumatol. 2008 Jul-Aug;26(4 Suppl
50):S49-51.

122: Seven A, Güzel S, Aslan M, Hamuryudan V. Serum and synovial fluid leptin
levels and markers of inflammation in rheumatoid arthritis. Rheumatol Int. 2009
May;29(7):743-7.

123: Ateş O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Genetic
susceptibility to Behçet's syndrome is associated with NRAMP1 (SLC11A1)
polymorphism in Turkish patients. Rheumatol Int. 2009 May;29(7):787-91.

124: Uğurlu U, Ozkan M, Ozdoğan H. The development of a new orthosis
(neuro-orthosis) for patients with carpal tunnel syndrome: its effect on the
function and strength of the hand. Prosthet Orthot Int. 2008 Dec;32(4):403-21.

125: Ozenoglu A, Balci H, Ugurlu S, Caglar E, Uzun H, Sarkis C, Gunay C, E EE.
The relationships of leptin, adiponectin levels and paraoxonase activity with
metabolic and cardiovascular risk factors in females treated with psychiatric
drugs. Clinics (Sao Paulo). 2008 Oct;63(5):651-60.

126: Hamuryudan V, Seyahi E, Yazici H. Comment on "Cardiac Behçet disease
presenting as aortic valvulitis/aortitis or right heart inflammatory mass: a
clinicopathologic study of 12 cases". Am J Surg Pathol. 2008 Dec;32(12):1914-5;
author reply 1915-6.

127: Yazici Y, Yazici H. Tumor necrosis factor alpha inhibitors, methotrexate or
both? An inquiry into the formal evidence for when they are to be used in
rheumatoid arthritis. Clin Exp Rheumatol. 2008 May-Jun;26(3):449-52.

128: Bilsel N, Gökçe A, Kesmezacar H, Mumcuoğlu E, Ozdoğan H. [Long-term results
of total hip arthroplasty in patients with juvenile rheumatoid arthritis]. Acta
Orthop Traumatol Turc. 2008 Mar-Apr;42(2):119-24.

129: Demirkesen C, Tüzüner N, Senocak M, Türkmen I, Aki H, Kepil N, Mat C, Yazici
H. Comparative study of adhesion molecule expression in nodular lesions of Behçet
syndrome and other forms of panniculitis. Am J Clin Pathol. 2008 Jul;130(1):28-33.

130: Yazici H. What is wrong with what is said? Bull NYU Hosp Jt Dis.
2008;66(2):140-2.

131: Karadag B, Kilic H, Duman D, Ongen Z, Vural VA, Yazici H. Takayasu disease
with prominent pulmonary artery involvement: confusion with pulmonary disease
leading to delayed diagnosis. Mod Rheumatol. 2008;18(5):507-10.

132: Yazici Y, Adler NM, Yazici H. Most tumour necrosis factor inhibitor trials
in rheumatology are undeservedly called 'efficacy and safety' trials: a survey of
power considerations. Rheumatology (Oxford). 2008 Jul;47(7):1054-7.

133: Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among
Behçet's syndrome patients with acne and arthritis: an ultrasonography study.
Arthritis Rheum. 2008 May;58(5):1539-45.

134: Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Tumor necrosis
factor-alpha and interleukin-10 gene promoter polymorphisms in Turkish rheumatoid
arthritis patients. Clin Rheumatol. 2008 Oct;27(10):1243-8.

135: Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,
Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N,
Yurdakul S, Yazici H. Management of Behçet disease: a systematic literature
review for the European League Against Rheumatism evidence-based recommendations
for the management of Behçet disease. Ann Rheum Dis. 2009 Oct;68(10):1528-34.

136: Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG,
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European
Vasculitis Study Group. EULAR recommendations for the management of primary small
and medium vessel vasculitis. Ann Rheum Dis. 2009 Mar;68(3):310-7.

137: Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T,
Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG,
Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R; European
Vasculitis Study Group. EULAR recommendations for the management of large vessel
vasculitis. Ann Rheum Dis. 2009 Mar;68(3):318-23.

138: Sahin N, Aksu K, Kamali S, Bicakcigil M, Ozbalkan Z, Fresko I, Ozer H, Akar
S, Onat AM, Cobankara V, Kiraz S, Oztürk MA, Tunç E, Yücel E, Ates A, Keser G,
Inanc M, Direskeneli H, Saruhan-Direskeneli G; RAED Vasculitis Study Group.
PTPN22 gene polymorphism in Takayasu's arteritis. Rheumatology (Oxford). 2008
May;47(5):634-5.

139: Hatemi G, Melikoglu M, Sut N, Yazici H. Purified protein derivative reaction
is not augmented in Behçet's syndrome patients. Rheumatology (Oxford). 2008
May;47(5):733-4.

140: Seven A, Güzel S, Aslan M, Hamuryudan V. Lipid, protein, DNA oxidation and
antioxidant status in rheumatoid arthritis. Clin Biochem. 2008;41(7-8):538-43.

141: Ugurlu S, Caglar E, Yesim T, Balci H, Tasan E. Anti-Scl-70 antibodies in
autoimmune hypothyroidism. J Int Med Res. 2008 Jan-Feb;36(1):152-6.

142: Erdem TY, Ercan M, Ugurlu S, Balci H, Acbay O, Gundogdu S. Plasma viscosity,
an early cardiovascular risk factor in women with subclinical hypothyroidism.
Clin Hemorheol Microcirc. 2008;38(4):219-25.

143: Pay S; Society for Research and Education in Rheumatology of Turkey. Risk of
cancer in Turkish patients after treatment with TNF antagonists. Rheumatology
(Oxford). 2008 Apr;47(4):548-9.

144: Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V,
Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M, Schachna L,
Sieper J, Boumpas DT, Dougados M. Evidence-based recommendations for the
management of ankylosing spondylitis: systematic literature search of the 3E
Initiative in Rheumatology involving a broad panel of experts and practising
rheumatologists. Rheumatology (Oxford). 2008 Mar;47(3):355-61.

145: Ugurlu S, Seyahi E, Yazici H. Prevalence of angina, myocardial infarction
and intermittent claudication assessed by Rose Questionnaire among patients with
Behcet's syndrome. Rheumatology (Oxford). 2008 Apr;47(4):472-5.

146: Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH,
Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N,
Yurdakul S, Yazici H; EULAR Expert Committee. EULAR recommendations for the
management of Behçet disease. Ann Rheum Dis. 2008 Dec;67(12):1656-62.

147: Seyahi E, Ugurlu S, Cumali R, Balci H, Ozdemir O, Melikoglu M, Hatemi G,
Fresko I, Hamuryudan V, Yurdakul S, Yazici H. Atherosclerosis in Behçet's
Syndrome. Semin Arthritis Rheum. 2008 Aug;38(1):1-12.

148: Melikoglu M, Kural-Seyahi E, Tascilar K, Yazici H. The unique features of
vasculitis in Behçet's syndrome. Clin Rev Allergy Immunol. 2008 Oct;35(1-2):40-6.

149: Direskeneli H, Ergun T, Yavuz S, Hamuryudan V, Eksioglu-Demiralp E.
Thalidomide has both anti-inflammatory and regulatory effects in Behcet's
disease. Clin Rheumatol. 2008 Mar;27(3):373-5.

150: Saruhan-Direskeneli G, Inanc M, Fresko I, Akkoc N, Dalkilic E, Erken E,
Karaaslan Y, Kinikli G, Oksel F, Pay S, Yucel E, Yentür SP, Duymaz-Tozkir J,
Yilmaz V, Inanc N, Yazici H, Konice M, Direskeneli H. The role of HLA-DRB1 shared
epitope alleles in predicting short-term response to leflunomide in rheumatoid
arthritis. Rheumatology (Oxford). 2007 Dec;46(12):1842-4.

151: Tunc R, Caglayan-Tunc A, Kisakol G, Unler GK, Hidayetoglu T, Yazici H.
Intraobserver and interobserver agreements of leg circumference measurements by
tape measure based on 3 reference points. Angiology. 2007 Oct-Nov;58(5):593-6.

152: Seyahi E, Yazici H. Atherosclerosis in Behçet's syndrome. Clin Exp
Rheumatol. 2007 Jul-Aug;25(4 Suppl 45):S1-5.

153: Alturfan AA, Uslu E, Alturfan EE, Hatemi G, Fresko I, Kokoglu E. Increased
serum sialic acid levels in primary osteoarthritis and inactive rheumatoid
arthritis. Tohoku J Exp Med. 2007 Nov;213(3):241-8.

154: Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW,
Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J,
Yazici H, Luqmani RA; European Vasculitis Study Group (EUVAS). Outcomes from
studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic
review by the European League Against Rheumatism systemic vasculitis task force.
Ann Rheum Dis. 2008 Jul;67(7):1004-10.

155: Yazici H. Use and abuse of the controlled clinical trial. Bull NYU Hosp Jt
Dis. 2007;65(2):132-4.

156: Hazenberg BP, Bijzet J, Limburg PC, Skinner M, Hawkins PN, Butrimiene I,
Livneh A, Lesnyak O, Nasonov EL, Filipowicz-Sosnowska A, Gül A, Merlini G, Wiland
P, Ozdogan H, Gorevic PD, Maïz HB, Benson MD, Direskeneli H, Kaarela K, Garceau
D, Hauck W, Van Rijswijk MH. Diagnostic performance of amyloid A protein
quantification in fat tissue of patients with clinical AA amyloidosis. Amyloid.
2007 Jun;14(2):133-40. Erratum in: Amyloid. 2007 Dec;14(4):325.

157: Seyahi E, Hamuryudan V, Hatemi G, Melikoglu M, Celik S, Fresko I, Yurdakul
S, Yazici H. Infliximab in the treatment of hepatic vein thrombosis (Budd-Chiari
syndrome) in three patients with Behcet's syndrome. Rheumatology (Oxford). 2007
Jul;46(7):1213-4. Epub 2007 May 3.

158: Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D,
Yalçinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E,
Pugnère D, Michelon C, Séguret F, Gershoni-Baruch R; International Study Group
for Phenotype-Genotype Correlation in Familial Mediterranean Fever. Country as
the primary risk factor for renal amyloidosis in familial Mediterranean fever.
Arthritis Rheum. 2007 May;56(5):1706-12.

159: Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A,
Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis
P, Yazici H. Anti-TNF therapy in the management of Behcet's disease--review and
basis for recommendations. Rheumatology (Oxford). 2007 May;46(5):736-41.

160: Kahveci A, Seyahi N, Seyahi E, Altiparmak MR, Ataman R, Serdengecti K.
Homozygous factor V Leiden mutation and disseminated thrombosis in a patient with
nephrotic syndrome. J Nephrol. 2007 Jan-Feb;20(1):103-6.

161: Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations,
management, and advances in treatment. Nat Clin Pract Rheumatol. 2007;3(3):148-55.

162: Hatemi G, Melikoglu M, Fresko I, Masatlioglu S, Tascilar K, Yazici H.
Infliximab does not suppress the tuberculin skin test (purified protein
derivative). J Rheumatol. 2007 Mar;34(3):474-80.

163: Oliveira S, Ravelli A, Pistorio A, Castell E, Malattia C, Prieur AM,
Saad-Magalhães C, Murray KJ, Bae SC, Joos R, Foeldvari I, Duarte-Salazar C,
Wulffraat N, Lahdenne P, Dolezalova P, de Inocencio J, Kanakoudi-Tsakalidou F,
Hofer M, Nikishina I, Ozdogan H, Hashkes PJ, Landgraf JM, Martini A, Ruperto N;
Pediatric Rheumatology International Trials Organization (PRINTO). Proxy-reported
health-related quality of life of patients with juvenile idiopathic arthritis:
the Pediatric Rheumatology International Trials Organization multinational
quality of life cohort study. Arthritis Rheum. 2007 Feb 15;57(1):35-43.

164: Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C,
Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S. Colchicine use in children
and adolescents with familial Mediterranean fever: literature review and
consensus statement. Pediatrics. 2007 Feb;119(2):e474-83.

165: Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L,
Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA.
EULAR recommendations for conducting clinical studies and/or clinical trials in
systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated
vasculitis. Ann Rheum Dis. 2007 May;66(5):605-17.

166: Yazici Y, Yazici H. Comment on 'Drug-related pulmonary problems in patients
with rheumatoid arthritis'. Rheumatology (Oxford). 2007 Feb;46(2):371-2;

167: Sut N, Seyahi E, Yurdakul S, Senocak M, Yazici H. A cost analysis of
Behcet's syndrome in Turkey. Rheumatology (Oxford). 2007 Apr;46(4):678-82.

168: Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in
colchicine resistant familial Mediterranean fever patients: thalidomide and
etanercept as adjunctive agents. Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl
42):S99-103.

169: Tasli L, Mat C, De Simone C, Yazici H. Lactobacilli lozenges in the
management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol. 2006
Sep-Oct;24(5 Suppl 42):S83-6.

170: Seyahi E, Fresko I, Melikoglu M, Yazici H. The management of Behçet's
syndrome. Acta Reumatol Port. 2006 Apr-Jun;31(2):125-31.

171: Melikoglu M, Uysal S, Krueger JG, Kaplan G, Gogus F, Yazici H, Oliver S.
Characterization of the divergent wound-healing responses occurring in the
pathergy reaction and normal healthy volunteers. J Immunol. 2006 Nov
1;177(9):6415-21.

172: Saruhan-Direskeneli G, Biçakçigil M, Yilmaz V, Kamali S, Aksu K, Fresko I,
Akkoç N, Kiraz S, Ozer HT, Tunç E, Yücel E, Karaarslan Y, Uyar FA, Doganavşargil
E, Inanc M, Direskeneli H; Rheumatology Education and Research Society Vasculitis
Study Group. Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's
arteritis from Turkey. Hum Immunol. 2006 Sep;67(9):735-40.

173: Yazici Y, Yazici H. Trial of etanercept and methotrexate with radiographic
and patient outcomes two-year clinical and radiographic results: Comment on the
article by van der Heijde et al. Arthritis Rheum. 2006 Sep;54(9):3061-2.

174: Yurdakul S. Prevalence of rheumatoid arthritis. J Rheumatol. 2006
Aug;33(8):1710; author reply 1710.

175: Yazici Y, Yazici H. A survey of inclusion of the time element when reporting
adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour
necrosis factor alpha inhibitors. Ann Rheum Dis. 2007 Jan;66(1):124-7.

176: Seyahi E, Seyahi N, Fresko I, Kuyumcu M, Yazici H. Hair diameter in systemic
lupus erythematosus. Lupus. 2006;15(5):282-4.

177: Mat MC, Goksugur N, Engin B, Yurdakul S, Yazici H. The frequency of scarring
after genital ulcers in Behçet's syndrome: a prospective study. Int J Dermatol.
2006 May;45(5):554-6.

178: Akman-Demir G, Gul A, Gurol E, Ozdogan H, Bahar S, Oge AE, Gurvit H,
Saruhan-Direskeneli G, Yazici H, Eraksoy M. Inflammatory/demyelinating central
nervous system involvement in familial Mediterranean fever (FMF): coincidence or
association? J Neurol. 2006 Jul;253(7):928-34. Epub 2006 Mar 6.

179: Yazici Y, Yazici H. Use of statistical analysis in open extension studies. J
Rheumatol. 2006 Feb;33(2):437; author reply 437-8.

180: Seyahi E, Ugurlu S, Cumali R, Balci H, Seyahi N, Yurdakul S, Yazici H.
Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006 Sep;65(9):1202-7.

181: Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P,
Ferraccioli G, Hazes JM, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman
A, Smolen J, Yazici H. EULAR recommendations for the management of early
arthritis: report of a task force of the European Standing Committee for
International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis.
2007 Jan;66(1):34-45.

182: Pincus T, Yazici Y, Yazici H, Kavanaugh AF, Kremer JM, Wolfe F. Radiographic
benefit without clinical improvement in infliximab-treated patients with
rheumatoid arthritis: comment on the article by Smolen et al. Arthritis Rheum.
2005 Dec;52(12):4044-5; author reply 4045-7.

183: Fresko I, Ugurlu S, Ozbakir F, Celik A, Yurdakul S, Hamuryudan V, Yazici H.
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin Exp
Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S67-70.

184: Gogus F, Fresko I, Elbir Y, Eksioglu-Demiralp E, Direskeneli H. Oxidative
burst response to monosodium urate crystals in patients with Behçet's syndrome.
Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S81-5.

185: Yurdakul S, Hekim N, Soysal T, Fresko I, Bavunoglu I, Ozbakir F, Tabak F,
Melikoglu M, Hamuryudan V, Yazici H. Fibrinolytic activity and d-dimer levels in
Behçet's syndrome. Clin Exp Rheumatol. 2005 Jul-Aug;23(4 Suppl 38):S53-8.

186: Mat C, Yurdakul S, Uysal S, Gogus F, Ozyazgan Y, Uysal O, Fresko I, Yazici
H. A double-blind trial of depot corticosteroids in Behçet's syndrome.
Rheumatology (Oxford). 2006 Mar;45(3):348-52. Epub 2005 Nov 1.

187: Saip S, Siva A, Altintas A, Kiyat A, Seyahi E, Hamuryudan V, Yazici H.
Headache in Behçet's syndrome. Headache. 2005 Jul-Aug;45(7):911-9.

188: Cem Ar M, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful
management of cryoglobulinemia-induced leukocytoclastic vasculitis with
thalidomide in a patient with multiple myeloma. Ann Hematol. 2005
Sep;84(9):609-13.
189: Akpolat T, Yilmaz E, Ozdogan H, Melikoglu M, Altiok E, Ozen S. Do MEFV
mutations play a role in the development of Behçet's disease related amyloidosis?
Clin Exp Rheumatol. 2005 Mar-Apr;23(2):273-4.

190: Ruperto N, Garcia-Munitis P, Villa L, Pesce M, Aggarwal A, Fasth A, Avcin T,
Bae SC, Balogh Z, Li C, De Inocencio J, Dibra M, Dolezalova P, El Miedany Y,
Flato B, Harjacek M, Huppertz HI, Kanakoudi-Tsakalidou F, Wulffraat N, Lahdenne
P, Melo-Gomes JA, Mihaylova D, Nielsen S, Nikishina I, Ozdogan H, Pagava K,
Panaviene V, Prieur AM, Romicka AM, Rumba I, Shafaie N, Susic G, Takei S, Uziel
Y, Vesely R, Woo P, Martini A; Paediatric Rheumatology International Trials
Organisation; Paediatric Rheumatology European Society. PRINTO/PRES international
website for families of children with rheumatic diseases:
www.pediatric-rheumatology.printo.it. Ann Rheum Dis. 2005 Jul;64(7):1101-6.

191: Tunca M, Ozdogan H. Molecular and genetic characteristics of hereditary
autoinflammatory diseases. Curr Drug Targets Inflamm Allergy. 2005
Feb;4(1):77-80.

192: Inanc N, Mumcu G, Birtas E, Elbir Y, Yavuz S, Ergun T, Fresko I, Direskeneli
H. Serum mannose-binding lectin levels are decreased in behcet's disease and
associated with disease severity. J Rheumatol. 2005 Feb;32(2):287-91.

193: Engin B, Mat MC, Demirkesen C, Kotogyan A, Ozdogan H. Scleredema adultorum
associated with hyperkeratosis. Pediatr Dermatol. 2005 Jan-Feb;22(1):36-9.

194: Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E,
Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc
A, Erken E; Turkish FMF Study Group. Familial Mediterranean fever (FMF) in
Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005
Jan;84(1):1-11.

195: Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V,
Yazici H. Short-term trial of etanercept in Behçet's disease: a double blind,
placebo controlled study. J Rheumatol. 2005 Jan;32(1):98-105.

196: Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behçet
disease. Curr Opin Rheumatol. 2005 Jan;17(1):1-8.

197: Fresko I, Seyahi E, Yurdakul S. Infliximab and primary Sjogren's syndrome:
comment on the article by Mariette et al. Arthritis Rheum. 2004 Dec;50(12):4077;
author reply 4077-8.

198: Hamuryudan V, Er T, Seyahi E, Akman C, Tüzün H, Fresko I, Yurdakul S, Numan
F, Yazici H. Pulmonary artery aneurysms in Behçet syndrome. Am J Med. 2004 Dec
1;117(11):867-70.

199: Yazici H. Is the STAR trial really a safety trial? J Rheumatol. 2004
Dec;31(12):2528; author reply 2528-9.

200: Tunc R, Saip S, Siva A, Yazici H. Cerebral venous thrombosis is associated
with major vessel disease in Behçet's syndrome. Ann Rheum Dis. 2004
Dec;63(12):1693-4.

201: Kasapçopur O, Yologlu N, Ozyazgan Y, Ercan G, Caliskan S, Sever L, Ozdogan
H, Arisoy N. Uveitis and anti nuclear antibody positivity in children with
juvenile idiopathic arthritis. Indian Pediatr. 2004 Oct;41(10):1035-9.

202: Yazici Y, Erkan D, Ince A, Nesher G, Kural E, Seyahi N, Moore TL. Behçet's
disease: does lack of knowledge result in under-diagnosis? Clin Exp Rheumatol.
2004 Jul-Aug;22(4 Suppl 34):81-2.

203: Erkan D, Yazici Y, Sanders A, Trost D, Yazici H. Is Hughes-Stovin syndrome
Behçet's disease? Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S64-8.

204: Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased
frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp
Rheumatol. 2004 Jul-Aug;22(4 Suppl 34):S31-3.

205: Hamuryudan V, Oz B, Tüzün H, Yazici H. The menacing pulmonary artery
aneurysms of Behçet's syndrome. Clin Exp Rheumatol. 2004 Jul-Aug;22(4 Suppl
34):S1-3.

206: Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, Altas K, Yazici
H. The pustular skin lesions in Behcet's syndrome are not sterile. Ann Rheum Dis.
2004 Nov;63(11):1450-2.

207: Seyahi E, Memisoglu E, Hamuryudan V, Tepe S, Aker UT, Balci H, Ongen Z,
Yurdakul S, Yazici H. Coronary atherosclerosis in Behçet's syndrome: a pilot
study using electron-beam computed tomography. Rheumatology (Oxford). 2004
Nov;43(11):1448-50.

208: Hatemi G, Masatlioglu S, Gogus F, Ozdogan H. Necrotizing vasculitis
associated with familial Mediterranean fever. Am J Med. 2004 Oct 1;117(7):516-9.

209: Caliskan R, Masatlioglu S, Aslan M, Altun S, Saribas S, Ergin S, Uckan E,
Koksal V, Oz V, Altas K, Fresko I, Kocazeybek B. The relationship between
arthritis and human parvovirus B19 infection. Rheumatol Int. 2005 Nov;26(1):7-11.

210: Yazici H. The lumps and bumps of Behçet's syndrome. Autoimmun Rev. 2004
Jun;3 Suppl 1:S53-4.

211: Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F,
Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson
J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R,
Pistorio A, Woo P, Martini A; Pediatric Rheumatology International Trials
Organization. A randomized trial of parenteral methotrexate comparing an
intermediate dose with a higher dose in children with juvenile idiopathic
arthritis who failed to respond to standard doses of methotrexate. Arthritis
Rheum. 2004 Jul;50(7):2191-201.

212: Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, Direskeneli H. Oral
health is impaired in Behçet's disease and is associated with disease severity.
Rheumatology (Oxford). 2004 Aug;43(8):1028-33.

213: Tunc R, Gonen MS, Acbay O, Hamuryudan V, Yazici H. Autoimmune thyroiditis
and anti-thyroid antibodies in primary Sjogren's syndrome: a case-control study.
Ann Rheum Dis. 2004 May;63(5):575-7.

214: Kasapçopur O, Demirli N, Ozdoğan H, Apelyan M, Calişkan S, Sever L, Arisoy
N. Evaluation of classification criteria for juvenile-onset
spondyloarthropathies. Rheumatol Int. 2005 Aug;25(6):414-8.

215: Altiparmak MR, Pamuk ON, Fresko I. Massive hematuria in rheumatoid
arthritis: an unusual manifestation of reactive amyloidosis. Clin Exp Rheumatol.
2003 Nov-Dec;21(6):799-800.

216: Dinc A, Takafuta T, Jiang D, Melikoglu M, Saruhan-Direskeneli G, Shapiro SS.
Anti-endothelial cell antibodies in Behçet's disease. Clin Exp Rheumatol. 2003
Jul-Aug;21(4 Suppl 30):S27-30.

217: Bilsel N, Aydingöz O, Kesmezacar H, Oğüt T, Ozdoğan H. An ankylosing
spondylitis patient 'with no joints'. Clin Rheumatol. 2003 Dec;22(6):502.

218: Yurdakul S, Hamuryudan V, Yazici H. Behçet syndrome. Curr Opin Rheumatol.
2004 Jan;16(1):38-42.

219: Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M,
Mathema B, Ramaswamy SV, Walther G, Steyn LM, Barry CE 3rd, Bekker LG.
Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with
failed immunity. Infect Immun. 2003 Dec;71(12):7099-108.

220: Tabak F, Tanverdi M, Ozaras R, Mert A, Tartan Z, Ozturk R, Aktuglu Y.
Neutrophilic pleocytosis in cerebrospinal fluid: adult-onset Still's disease.
Intern Med. 2003 Oct;42(10):1039-41.

221: Hamuryudan V. [Rules for writing the medical manuscript]. Anadolu Kardiyol
Derg. 2003 Sep;3(3):199-202.

222: Yazici H. Lymphomas after tumor necrosis factor antagonist therapy: comment
on the article by Brown et al. Arthritis Rheum. 2003 Aug;48(8):2389.

223: Touitou I, Ben-Chetrit E, Gershoni-Baruch R, Grateau G, Kastner DL,
Kone-Paut I, Livneh A, Manna R, Mansour I, Ozdogan H, Ozen S, Sarkisian T, Tunca
M, Yalcinkaya F. Allogenic bone marrow transplantation: not a treatment yet for
familial Mediterranean fever. Blood. 2003 Jul 1;102(1):409.

224: Yazici H. Behçet's syndrome: an update. Curr Rheumatol Rep. 2003
Jun;5(3):195-9.

225: Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H, Aktuglu Y. Fever of
unknown origin: a review of 20 patients with adult-onset Still's disease. Clin
Rheumatol. 2003 May;22(2):89-93.

226: Korman U, Cantasdemir M, Kurugoglu S, Mihmanli I, Soylu N, Hamuryudan V,
Yazici H. Enteroclysis findings of intestinal Behcet disease: a comparative study
with Crohn disease. Abdom Imaging. 2003 May-Jun;28(3):308-12.

227: Kantarcioğlu AS, Hatemi G, Yücel A, De Hoog GS, Mandel NM. Paecilomyces
variotii central nervous system infection in a patient with cancer. Mycoses. 2003
Feb;46(1-2):45-50.

228: Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V,
Yurdakul S, Yazici H. The long-term mortality and morbidity of Behçet syndrome: a
2-decade outcome survey of 387 patients followed at a dedicated center. Medicine
(Baltimore). 2003 Jan;82(1):60-76.

229: Altintas A, Alici Y, Melikoğlu M, Siva A. Arthritis during interferon
beta-1b treatment in multiple sclerosis. Mult Scler. 2002 Dec;8(6):534-6.

230: Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H. Interferon
alfa combined with azathioprine for the uveitis of Behçet's disease: an open
study. Isr Med Assoc J. 2002 Nov;4(11 Suppl):928-30.

231: Tunc R, Keyman E, Melikoglu M, Fresko I, Yazici H. Target organ associations
in Turkish patients with Behçet's disease: a cross sectional study by exploratory
factor analysis. J Rheumatol. 2002 Nov;29(11):2393-6.

232: Fresko I. Highlights of the 10th International Congress on Behçet's Disease.
Clin Exp Rheumatol. 2002 Jul-Aug;20(4 Suppl 26):S59-64.

233: Altiparmak MR, Pamuk ON, Pamuk GE, Hamuryudan V, Ataman R, Serdengecti K.
Colchicine neuromyopathy: a report of six cases. Clin Exp Rheumatol. 2002
Jul-Aug;20(4 Suppl 26):S13-6.

234: Ben-Chetrit E, Yazici H. Thoughts on the proposed links between Behçet's
disease and familial Mediterranean fever. Clin Exp Rheumatol. 2002 Jul-Aug;20(4
Suppl 26):S1-2.

235: Altiparmak MR, Tanverdi M, Pamuk ON, Tunç R, Hamuryudan V.
Glomerulonephritis in Behçet's disease: report of seven cases and review of the
literature. Clin Rheumatol. 2002 Feb;21(1):14-8.

236: Yazici Y, Erkan D, Harrison MJ, Peterson MG, Yazici H. Reporting consistency
in systemic lupus erythematosus patients: how reliable are patient histories?
Lupus. 2002;11(1):46-8.

237: Korkmaz C, Ozdogan H, Kasapçopur O, Yazici H. Acute phase response in
familial Mediterranean fever. Ann Rheum Dis. 2002 Jan;61(1):79-81.

238: Savgan-Gürol E, Kasapçopur O, Hatemi S, Ercan O, Caliskan S, Sever L,
Ozdogan H, Arisoy N. Growth and IGF-1 levels of children with familial
Mediterranean fever on colchicine treatment. Clin Exp Rheumatol. 2001
Sep-Oct;19(5 Suppl 24):S72-5.

239: Tunç R, Uluhan A, Melikoğlu M, Ozyazgan Y, Ozdoğan H, Yazici H. A
reassessment of the International Study Group criteria for the diagnosis
(classification) of Behçet's syndrome. Clin Exp Rheumatol. 2001 Sep-Oct;19(5
Suppl 24):S45-7.

240: Dinç A, Melikoğlu M, Korkmaz C, Fresko I, Ozdoğan H, Yazici H. Nailfold
capillary abnormalities in patients with familial Mediterranean fever. Clin Exp
Rheumatol. 2001 Sep-Oct;19(5 Suppl 24):S42-4.

241: Aral O, Ozdogan H, Yazici H. The other physician behind the use of
colchicine for the treatment of familial Mediterranean fever. Clin Exp Rheumatol.
2001 Sep-Oct;19(5 Suppl 24):S13-4.

242: Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M,
Yazici H. A double-blind trial of colchicine in Behçet's syndrome. Arthritis
Rheum. 2001 Nov;44(11):2686-92.

243: Kötter I, Günaydin I, Stübiger N, Yazici H, Fresko I, Zouboulis CC, Adler Y,
Steiert I, Kurz B, Wernet D, Braun B, Müller CA. Comparative analysis of the
association of HLA-B*51 suballeles with Behçet's disease in patients of German
and Turkish origin. Tissue Antigens. 2001 Sep;58(3):166-70.

244: Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H. Papulopustular
skin lesions are seen more frequently in patients with Behçet's syndrome who have
arthritis: a controlled and masked study. Ann Rheum Dis. 2001 Nov;60(11):1074-6.

245: Demirkesen C, Tüzüner N, Mat C, Senocak M, Büyükbabani N, Tüzün Y, Yazici H.
Clinicopathologic evaluation of nodular cutaneous lesions of Behçet syndrome. Am
J Clin Pathol. 2001 Sep;116(3):341-6.

246: Pamuk GE, Pamuk ON, Altiparmak MR, Tanverdi M, Uygun N, Yurdakul S.
Secondary amyloidosis in progressive systemic sclerosis. Clin Rheumatol.
2001;20(4):285-7.

247: Ozdogan H, Ruperto N, Kasapçopur O, Bakkaloglu A, Arisoy N, Ozen S, Ugurlu
U, Unsal E, Melikoglu M; Paediatric Rheumatology International Trials
Organisation. The Turkish version of the Childhood Health Assessment
Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp
Rheumatol. 2001 Jul-Aug;19(4 Suppl 23):S158-62.

248: Siva A, Kantarci OH, Saip S, Altintas A, Hamuryudan V, Islak C, Koçer N,
Yazici H. Behçet's disease: diagnostic and prognostic aspects of neurological
involvement. J Neurol. 2001 Feb;248(2):95-103.

249: Melikoğlu M, Altiparmak MR, Fresko I, Tunç R, Yurdakul S, Hamuryudan V,
Yazici H. A reappraisal of amyloidosis in Behçet's syndrome. Rheumatology
(Oxford). 2001 Feb;40(2):212-5.

250: Tokay S, Direskeneli H, Yurdakul S, Akoglu T. Anticardiolipin antibodies in
Behçet's disease: a reassessment. Rheumatology (Oxford). 2001 Feb;40(2):192-5.

251: Yazici H, Biyikli M, van der Linden S, Schouten HJ. The 'zero patient'
design to compare the prevalences of rare diseases. Rheumatology (Oxford). 2001
Feb;40(2):121-2.

252: Yazici H, Yurdakul S, Hamuryudan V. Behçet disease. Curr Opin Rheumatol.
2001 Jan;13(1):18-22.

253: Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoğlu M, Tunç R,
Yurdakul S, Yazici H. Intestinal permeability in Behçet's syndrome. Ann Rheum
Dis. 2001 Jan;60(1):65-6.

254: Siva A, Fresko I I. Behçet's Disease. Curr Treat Options Neurol. 2000
Sep;2(5):435-448.

255: Melikoğlu M, Ozdoğan H, Korkmaz C, Kasapçopur O, Arisoy N, Akkuş S, Fresko
Z, Yazici H. A survey of phenotype II in familial Mediterranean fever. Ann Rheum
Dis. 2000 Nov;59(11):910-3.

256: Kasapçopur O, Ozbakir F, Arisoy N, Ingöl H, Yazici H, Ozdoğan H. Frequency
of antinuclear antibodies and rheumatoid factor in healthy Turkish children. Turk
J Pediatr. 1999 Jan-Mar;41(1):67-71.

257: Eksioglu-Demiralp E, Direskeneli H, Ergun T, Fresko I, Akoglu T. Increased
CD4+CD16+ and CD4+CD56+ T cell subsets in Behçet's disease. Rheumatol Int.
1999;19(1-2):23-6.

258: Yazici H, Ozyazgan Y. Medical management of Behçet's syndrome. Dev
Ophthalmol. 1999;31:118-31.

259: Fresko I, Yurdakul S, Hamuryudan V, Ozyazgan Y, Mat C, Tanverdi MM, Yazici
H. The management of Behçet's syndrome. Ann Med Interne (Paris). 1999
Nov;150(7):576-81.

260: Apaydin S, Erek E, Ulkü U, Hamuryudan V, Yazici H, Sariyar M. A successful
renal transplantation in Behçet's syndrome. Ann Rheum Dis. 1999 Nov;58(11):719.

261: Yazici H, Fresko I, Hamuryudan V, Mat C, Melikoglu M, Ozyazgan Y, Tuzun Y,
Yurdakul S. Behçet's syndrome. The Cerrahpasa experience. Members of the Behçet's
Syndrome Research Centre. Adv Exp Med Biol. 1999;455:135-40.

262: Barnes CG, Yazici H. Behçet's syndrome. Rheumatology (Oxford). 1999
Dec;38(12):1171-4.

263: Tüzün B, Tüzün Y, Yurdakul S, Hamuryudan V, Yazici H, Ozyazgan Y. Neutrophil
chemotaxis in Behçet's syndrome. Ann Rheum Dis. 1999 Oct;58(10):658.

264: Basaranoglu M, Mert A, Tabak F, Apaydin S, Aktuglu Y, Ozdogan H. A case of
familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous
bilateral perirenal and subcapsular splenic haemorrhage. Rheumatology (Oxford).
1999 Aug;38(8):794-6.

265: Hamuryudan V, Fresko I, Direskeneli H, Tenant MJ, Yurdakul S, Akoglu T,
Yazici H. Evaluation of the Turkish translation of a disease activity form for
Behçet's syndrome. Rheumatology (Oxford). 1999 Aug;38(8):734-6.

266: Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H. Serum soluble
intercellular adhesion molecule 1 and interleukin 8 levels in familial
Mediterranean fever. J Rheumatol. 1999 Sep;26(9):1983-6.

267: Ertan S, Fresko I, Apaydin H, Ozekmekçi S, Yazici H. Extrapyramidal type
rigidity in rheumatoid arthritis. Rheumatology (Oxford). 1999 Jul;38(7):627-30.

268: Koçer N, Islak C, Siva A, Saip S, Akman C, Kantarci O, Hamuryudan V. CNS
involvement in neuro-Behçet syndrome: an MR study. AJNR Am J Neuroradiol. 1999
Jun-Jul;20(6):1015-24.

269: Ozgüroğlu M, Ersavaşti G, Ilvan S, Hatemi G, Demir G, Demirelli FH.
Bilateral inflammatory breast metastases of epithelial ovarian cancer. Am J Clin
Oncol. 1999 Aug;22(4):408-10.

270: Ozdoğan H, Kasapçopur O, Arisoy N. Prevalence of juvenile chronic arthritis
and familial Mediterranean fever in Turkey: a field study. J Rheumatol. 1999
Jul;26(7):1638-9.

271: Koné-Paut I, Geisler I, Wechsler B, Ozen S, Ozdogan H, Rozenbaum M, Touitou
I. Familial aggregation in Behçet's disease: high frequency in siblings and
parents of pediatric probands. J Pediatr. 1999 Jul;135(1):89-93.

272: Korkmaz C, Fresko I, Yazici H. A case of systemic sclerosis that developed
under dexfenfluramine use. Rheumatology (Oxford). 1999 Apr;38(4):379-80.

273: Coban O, Bahar S, Akman-Demir G, Taşci B, Yurdakul S, Yazici H, Serdaroğlu
P. Masked assessment of MRI findings: is it possible to differentiate
neuro-Behçet's disease from other central nervous system diseases? [corrected].
Neuroradiology. 1999 Apr;41(4):255-60.

274: Yazici H, Yurdakul S, Hamuryudan V. The management of Behçet's syndrome: how
are we doing? Clin Exp Rheumatol. 1999 Mar-Apr;17(2):145-7.

275: Saylan T, Mat C, Fresko I, Melikoğlu M. Behçet's disease in the Middle East.
Clin Dermatol. 1999 Mar-Apr;17(2):209-23; discussion 105-6.

276: Ekşioglu-Demiralp E, Kibaroglu A, Direskeneli H, Yavuz S, Karsli F, Yurdakul
S, Yazici H, Akoglu T. Phenotypic characteristics of B cells in Behçet's disease:
increased activity in B cell subsets. J Rheumatol. 1999 Apr;26(4):826-32.

277: Cetinel B, Akpinar H, Tüfek I, Uygun N, Solok V, Yazici H. Bladder
involvement in Behçet's syndrome. J Urol. 1999 Jan;161(1):52-6.

278: Yazici H, Yurdakul S, Hamuryudan V. Behçet's syndrome. Curr Opin Rheumatol.
1999 Jan;11(1):53-7.

279: Direskeneli H, Ozdogan H, Yazici H. First International Conference on
familial Mediterranean fever, Jerusalem, Israel, September 7-11, 1997. J
Rheumatol. 1998 Nov;25(11):2236-9.

280: Yavuz S, Fresko I, Hamuryudan V, Yurdakul S, Yazici H. Fibromyalgia in
Behçet's syndrome. J Rheumatol. 1998 Nov;25(11):2219-20.

281: Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H. Urologic screening for
men with Behçet's syndrome. Urology. 1998 Nov;52(5):863-5.

282: Başak M, Gül S, Yazgan Y, Cankir Z, Danaci M, Demirtürk L, Tüzün H, Yurdakul
S. A case of rapidly progressive pulmonary aneurysm as a rare complication of
Behçet's syndrome--a case report. Angiology. 1998 May;49(5):403-8.

283: Mat MC, Nazarbaghi M, Tüzün Y, Hamuryudan V, Hizli N, Yurdakul S, Ozyazgan
Y, Yazici H. Wound healing in Behçet's syndrome. Int J Dermatol. 1998
Feb;37(2):120-3.

284: Koné-Paut I, Yurdakul S, Bahabri SA, Shafae N, Ozen S, Ozdogan H, Bernard
JL. Clinical features of Behçet's disease in children: an international
collaborative study of 86 cases. J Pediatr. 1998 Apr;132(4):721-5.

285: Ergun T, Gürbüz O, Dogusoy G, Mat C, Yazici H. Histopathologic features of
the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol. 1998
Mar;37(3):194-6.

286: Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Tümer Z, Yazici H.
Genetic anticipation in Behçet's syndrome. Ann Rheum Dis. 1998 Jan;57(1):45-8.

287: Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger
K, Yazici H. Thalidomide in the treatment of the mucocutaneous lesions of the
Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern
Med. 1998 Mar 15;128(6):443-50.

288: Ince A, Akhter IM, Moore TL, Basaran M, Yazici Y, Ozdogan H. Hidden 19S IgM
rheumatoid factors in Turkish patients with juvenile rheumatoid arthritis. J
Rheumatol. 1998 Jan;25(1):190-2.

289: Ergun T, Gürbüz O, Yurdakul S, Hamuryudan V, Bekiroğlu N, Yazici H. Topical
cyclosporine-A for treatment of oral ulcers of Behçet's syndrome. Int J Dermatol.
1997 Sep;36(9):720.

290: Kadioglu P, Hamuryudan V, Hekim N, Ozbakir F, Yurdakul S, Yazici H. Von
Willebrand factor antigen and angiotensin converting enzyme levels in Takayasu
arteritis. Br J Rheumatol. 1997 Aug;36(8):924-5.

291: Hamuryudan V, Ozdoğan H, Yazici H. Other forms of vasculitis and
pseudovasculitis. Baillieres Clin Rheumatol. 1997 May;11(2):335-55. Review.

292: Mat C, Yurdakul S, Tüzüner N, Tüzün Y. Small vessel vasculitis and
vasculitis confined to skin. Baillieres Clin Rheumatol. 1997 May;11(2):237-57.

293: Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tüzün Y, Senocak M,
Yazici H. Azathioprine in Behcet's syndrome: effects on long-term prognosis.
Arthritis Rheum. 1997 Apr;40(4):769-74.

294: Hamuryudan V, Ozyazgan Y, Yazici H. Treatment of Beçhet disease with
pentoxifylline. Ann Intern Med. 1997 Mar 15;126(6):493.

295: Tüzün H, Beşirli K, Sayin A, Vural FS, Hamuryudan V, Hizli N, Yurdakul S,
Yazici H. Management of aneurysms in Behçet's syndrome: an analysis of 24
patients. Surgery. 1997 Feb;121(2):150-6.

296: Ozdogan H, Arisoy N, Kasapçapur O, Sever L, Calişkan S, Tuzuner N, Mat C,
Yazici H. Vasculitis in familial Mediterranean fever. J Rheumatol. 1997
Feb;24(2):323-7.

297: Gabay C, Cakir N, Moral F, Roux-Lombard P, Meyer O, Dayer JM, Vischer T,
Yazici H, Guerne PA. Circulating levels of tumor necrosis factor soluble
receptors in systemic lupus erythematosus are significantly higher than in other
rheumatic diseases and correlate with disease activity. J Rheumatol. 1997
Feb;24(2):303-8.

298: Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome
emerging following thymectomy for myasthenia gravis: additional evidence for the
kaleidoscope of autoimmunity. Lupus. 1997;6(5):474-6.

299: Yazici H. The place of Behçet's syndrome among the autoimmune diseases. Int
Rev Immunol. 1997;14(1):1-10.

300: Melikoglu M, Apaydin S, Hamuryudan V, Yurdakul S, Uygun N, Aki H, Ozbay G,
Yazici H. Calciphylaxis: a condition mimicking necrotizing vasculitis. Clin
Rheumatol. 1996 Sep;15(5):498-500.

301: Ince A, Yazici Y, Hamuryudan V, Yazici H. The frequency and clinical
characteristics of methotrexate (MTX) oral toxicity in rheumatoid arthritis (RA):
a masked and controlled study. Clin Rheumatol. 1996 Sep;15(5):491-4.

302: Tüzün Y, Yurdakul S, Cem Mat M, Ozyazgan Y, Hamuryudan V, Tüzün B, Yazici H.
Epidemiology of Behçet's syndrome in Turkey. Int J Dermatol. 1996;35(9):618-20.

303: Akman-Demir G, Baykan-Kurt B, Serdaroglu P, Gürvit H, Yurdakul S, Yazici H,
Bahar S, Aktin E. Seven-year follow-up of neurologic involvement in Behçet
syndrome. Arch Neurol. 1996 Jul;53(7):691-4.

304: Yazici H, van der Linden S. The case-control study and its potential biases.
Clin Exp Rheumatol. 1996 Jul-Aug;14(4):355-8.

305: Coban O, Bahar S, Akman-Demir G, Serdaroğlu P, Baykan-Kurt B, Tolun R,
Yurdakul S, Yazici H. A controlled study of reliability and validity of MRI
findings in neuro-Behçet's disease. Neuroradiology. 1996 May;38(4):312-6.

306: Sahin S, Lawrence R, Direskeneli H, Hamuryudan V, Yazici H, Akoğlu T.
Monocyte activity in Behçet's disease. Br J Rheumatol. 1996 May;35(5):424-9.

307: Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H. Gastrointestinal
involvement in Behçet's syndrome: a controlled study. Ann Rheum Dis. 1996
Mar;55(3):208-10.

308: Yazici H, Başaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, Tüzün Y,
Ozyazgan Y, Dimitriyadis I. The ten-year mortality in Behçet's syndrome. Br J
Rheumatol. 1996 Feb;35(2):139-41.

309: Tüzün H, Hamuryudan V, Yildirim S, Beşirli K, Yörük Y, Yurdakul S, Yazici H.
Surgical therapy of pulmonary arterial aneurysms in Behçet's syndrome. Ann Thorac
Surg. 1996 Feb;61(2):733-5.

310: Gunaydin I, Maleitzke R, Gottl KH, Tschirdewahn B, Yazici H. Therapeutic
approaches of German and Turkish physicians to rheumatoid arthritis and to
osteoarthritis of the knee. Clin Rheumatol. 1996 Jan;15(1):55-8.

311: Hamuryudan V, Sonsuz A, Yurdakul S. More on hepatitis C virus and Behçet's
syndrome. N Engl J Med. 1995 Aug 3;333(5):322;

312: Moral F, Hamuryudan V, Yurdakul S, Yazici H. Inefficacy of azapropazone in
the acute arthritis of Behçet's syndrome: a randomized, double blind, placebo
controlled study. Clin Exp Rheumatol. 1995 Jul-Aug;13(4):493-5.

313: Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R,
Gaffney K, Mat C, Yazici H, al Ialaan A, et al. Mucocutaneous criteria for the
diagnosis of Behçet's disease: an analysis of clinicopathologic data from
multiple international centers. J Am Acad Dermatol. 1995 Jun;32(6):968-76.

314: Roux H, Fresko I. Behçet's disease: a disease in search of its etiology. Rev
Rhum Engl Ed. 1995 May;62(5):339-42.

315: Direskeneli H, Keser G, D'Cruz D, Khamashta MA, Akoğlu T, Yazici H, Yurdakul
S, Hamuryudan V, Ozgün S, Goral AJ, et al. Anti-endothelial cell antibodies,
endothelial proliferation and von Willebrand factor antigen in Behçet's disease.
Clin Rheumatol. 1995 Jan;14(1):55-61

316: Günaydin I, Ustündağ C, Kaner G, Pazarli H, Yurdakul S, Hamuryudan V, Yazici
Y, Yazici H. The prevalence of Sjögren's syndrome in Behçet's syndrome. J
Rheumatol. 1994 Sep;21(9):1662-4.

317: Melli M, Yazici H, Uçar A, Türker RK. Inhibitory effect of allopurinol on
adjuvant arthritis in rats. Agents Actions. 1994 Aug;42(1-2):56-9.

318: Imeryüz N, Yazici H, Koçak H, Erk M, Ozder A, Karcier SM, Ozkan M, Ongen G,
Yurdakul S, Ozdoğan H. Pericardial and pulmonary involvement in rheumatoid
arthritis in Turkey. Clin Rheumatol. 1994 Jun;13(2):239-43.

319: Hamuryudan V, Moral F, Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Direskeneli
H, Akoglu T, Yazici H. Systemic interferon alpha 2b treatment in Behçet's
syndrome. J Rheumatol. 1994 Jun;21(6):1098-100.

320: Hamuryudan V, Yurdakul S, Moral F, Numan F, Tüzün H, Tüzüner N, Mat C, Tüzün
Y, Ozyazgan Y, Yazïci H. Pulmonary arterial aneurysms in Behçet's syndrome: a
report of 24 cases. Br J Rheumatol. 1994 Jan;33(1):48-51.

321: Cakir N, Imeryüz N, Suna D, Gözükara Y, Serdaroğlu S, Mert A, Yazici H.
Urate crystal test in Behçet's syndrome. Br J Rheumatol. 1993 Dec;32(12):1112-4.

322: Fresko I, Yazici H, Bayramiçli M, Yurdakul S, Mat C. Effect of surgical
cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum
Dis. 1993 Aug;52(8):619-20.

323: Dede H, Ozdoğan H, Dumankar A, Aktuğlu Y, Tabak F, Yazic H. Tropical
pyomyositis in a temperate climate. Br J Rheumatol. 1993 May;32(5):435-6.

324: Fresko I, Yazici H, Işçi H, Yurdakul S. Genital ulceration in patients with
systemic lupus erythematosus. Lupus. 1993 Apr;2(2):135.

325: Günaydin I, Yazici H, Ozbakir F, Hamuryudan V, Yurdakul S. Lymphocytotoxic
antibodies in the healthy children of patients with Behçet's syndrome. J
Rheumatol. 1992 Dec;19(12):1996-8.

326: Oğuz O, Serdaroğlu S, Tüzün Y, Erdoğan N, Yazici H, Savaşkan H. Acute
febrile neutrophilic dermatosis (Sweet's syndrome) associated with Behçet's
disease. Int J Dermatol. 1992 Sep;31(9):645-6.

327: Ozkan M, Emel O, Ozdemir M, Yurdakul S, Koçak H, Ozdoğan H, Hamuryudan V,
Dirican A, Yazici H. M-mode, 2-D and Doppler echocardiographic study in 65
patients with Behçet's syndrome. Eur Heart J. 1992 May;13(5):638-41.

328: Ozyazgan Y, Yurdakul S, Yazici H, Tüzün B, Işçimen A, Tüzün Y, Aktunç T,
Pazarli H, Hamuryudan V, Müftüoğlu A. Low dose cyclosporin A versus pulsed
cyclophosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol.
1992 Apr;76(4):241-3.

329: Kasapçopur O, Ozdoğan H, Yazici H. Obesity and erythrocyte sedimentation
rate in children. J Pediatr. 1991 Nov;119(5):773-5.

330: Hamuryudan V, Yurdakul S, Rosenkaimer F, Yazici H. Inefficacy of topical
alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a
randomized, double blind trial. Br J Rheumatol. 1991 Oct;30(5):395-6.

331: Cakir N, Yazici H, Chamberlain MA, Barnes CG, Yurdakul S, Atasoy S, Akcasu
A, Iscimen A. Response to intradermal injection of monosodium urate crystals in
Behçet's syndrome. Ann Rheum Dis. 1991 Sep;50(9):634-6.

332: Hamuryudan V, Yurdakul S, Ozbakir F, Yazici H, Hekim H. Monozygotic twins
concordant for Behçet's syndrome. Arthritis Rheum. 1991 Aug;34(8):1071-2.

333: Ozdogan H, Kasapçopur O, Dede H, Arisoy N, Beceren T, Yurdakul S, Yazici H.
Juvenile chronic arthritis in a Turkish population. Clin Exp Rheumatol. 1991
Jul-Aug;9(4):431-5.

334: Ozsahin H, Haktan M, Ozbakir F, Aydin A, Yazici H. The type 1 diabetes and
HLA-DR in Turkey. Diabete Metab. 1991 Jul-Aug;17(4):421-3.

335: Hamuryudan V, Yurdakul S, Kural AR, Ince U, Yazici H. Diffuse proliferative
glomerulonephritis in Behçet's syndrome. Br J Rheumatol. 1991 Feb;30(1):63-4.

336: Soysal M, Denizci U, Alhan S, Hamuryudan V, Dede H, Yurdakul S, Altuğ A,
Yazici H. Splenic size in Behçet's syndrome. Br J Rheumatol. 1990
Dec;29(6):497-8.

337: Skare J, Yazici H, Erken E, Dede H, Cohen A, Milunsky A, Skinner M.
Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial
amyloidotic polyneuropathy. Hum Genet. 1990 Nov;86(1):89-90.

338: Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H. Amyloidosis in
Behçet's syndrome. Arthritis Rheum. 1990 Oct;33(10):1586-9.

339: Akoğlu TF, Direskeneli H, Yazici H, Lawrence R. TNF, soluble IL-2R and
soluble CD-8 in Behçet's disease. J Rheumatol. 1990 Aug;17(8):1107-8.

340: Yazici H, Pazarli H, Barnes CG, Tüzün Y, Ozyazgan Y, Silman A, Serdaroğlu S,
Oğuz V, Yurdakul S, Lovatt GE, et al. A controlled trial of azathioprine in
Behçet's syndrome. N Engl J Med. 1990 Feb 1;322(5):281-5.

341: Hamuryudan V, Yurdakul S, Serdaroglu S, Tüzün Y, Rosenkaimer F, Yazici H.
Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a
preliminary report. Clin Exp Rheumatol. 1990 Jan-Feb;8(1):51-4.

342: Lahesmaa-Rantala R, Toivanen A, Granfors K, Yurdakul S, Hamuryudan V, Yazici
H. Anti-Yersinia antibodies in patients with Behçet's disease. Arthritis Rheum.
1989 Nov;32(11):1494-5.

343: Yazici H. Heberden's nodes and osteoarthrosis of the hip. Ann Rheum Dis.
1989 Jul;48(7):614.

344: Serdaroğlu P, Yazici H, Ozdemir C, Yurdakul S, Bahar S, Aktin E. Neurologic
involvement in Behçet's syndrome. A prospective study. Arch Neurol. 1989
Mar;46(3):265-9.

345: Oguz V, Pazarli H, Ozyazgan Y, Yazici H, Yurdakul S, Tuzun Y, Serdaroglu S.
[Prognostic value of HLA B5 antigen in isolated anterior uveitis in Behçet's
disease]. J Fr Ophtalmol. 1989;12(6-7):431-2.

346: Haktan M, Aydin A, Bahat H, Tuysuz B, Yazici H, Altay S. Progressive
systemic scleroderma in an infant with partial phenylketonuria. J Inherit Metab
Dis. 1989;12(4):486-7.

347: Cem Mat M, Yazici H, Ozbakir F, Tüzün Y. The HLA association of lepromatous
leprosy and borderline lepromatous leprosy in Turkey. A preliminary study. Int J
Dermatol. 1988 May;27(4):246-7.

348: Yurdakul S, Günaydin I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y, Yazici H.
The prevalence of Behçet's syndrome in a rural area in northern Turkey. J
Rheumatol. 1988;15(5):820-2.

349: Toivanen A, Lahesmaa-Rantala R, Meurman O, Sappinen O, Kosunen T, Yazici H,
Yurdakul S, Ozbakir F, Müftüoglu A. Antibodies against Yersinia, Campylobacter,
Salmonella, and Chlamydia in patients with Behçet's disease. Arthritis Rheum.
1987 Nov;30(11):1315-7.

350: Yazici H, Mat C, Deniz S, Iscimen A, Yurdakul S, Tuzun Y, Hekim N, Yazici Y.
Sebum production is increased in Behçet's syndrome and even more so in rheumatoid
arthritis. Clin Exp Rheumatol. 1987 Oct-Dec;5(4):371-4.

351: Yazici H, Schreuder I, Yurdakul S, Ozbakir F. HLA-B27 in Turkish patients
with rheumatoid arthritis. Ann Rheum Dis. 1987 Sep;46(9):718.

352: Ozbakir F, Yazici H, Mat C, Tüzün Y, Yurdakul S, Yilmazer S. HLA antigens in
recurrent oral ulceration: evidence against a common disease spectrum with
Behçet's syndrome. Clin Exp Rheumatol. 1987 Jul-Sep;5(3):263-5.

353: Müftüoğlu AU, Pazarli H, Yurdakul S, Yazici H, Ulkü BY, Tüzün Y, Serdaroğlu
S, Altuğ E, Bahçecioğlu H, Güngen G. Short term cyclosporin A treatment of
Behçet's disease. Br J Ophthalmol. 1987 May;71(5):387-90.

354: Yazici H, Hekim N, Ozbakir F, Yurdakul S, Tüzün Y, Pazarli H, Müftüoğlu A.
Von Willebrand factor in Behçet's syndrome. J Rheumatol. 1987 Apr;14(2):305-6.

355: Yazici H, Turunç M, Ozdoğan H, Yurdakul S, Akinci A, Barnes CG. Observer
variation in grading sacroiliac radiographs might be a cause of 'sacroiliitis'
reported in certain disease states. Ann Rheum Dis. 1987 Feb;46(2):139-45.

356: Yazici H. Behçet's syndrome, a personal view. Clin Exp Rheumatol. 1987
Jan-Mar;5(1):1-3.

357: Müftüoğlu AU, Yazici H, Yurdakul S, Tüzün Y, Pazarli H, Güngen G, Deniz S.
Behçet's disease. Relation of serum C-reactive protein and erythrocyte
sedimentation rates to disease activity. Int J Dermatol. 1986 May;25(4):235-9.

358: Ulukutlu L, Yazici H, Cam H, Esen E, Ozbakir F. Histocompatibility antigens
(HLA) in acute lymphocytic leukemia. Turk J Pediatr. 1986 Apr-Jun;28(2):111-4.

359: Bulutlar G, Yazici H, Ozdoğan H, Schreuder I. A familial syndrome of
pericarditis, arthritis, camptodactyly, and coxa vara. Arthritis Rheum. 1986
Mar;29(3):436-8.

360: Ozdogan H, Turunç M, Deringöl B, Yurdakul S, Yazici H. Sulphasalazine in the
treatment of juvenile rheumatoid arthritis: a preliminary open trial. J
Rheumatol. 1986 Feb;13(1):124-5.

361: Yazici H, Tüzün Y, Tanman AB, Yurdakul S, Serdaroglu S, Pazarli H, Müftüoglu
A. Male patients with Behçet's syndrome have stronger pathergy reactions. Clin
Exp Rheumatol. 1985 Apr-Jun;3(2):137-41.

362: Pazarli H, Ozyazgan Y, Oguz V, Bahçecioglu H, Muftuoglu A, Yazici H,
Yurdakul S. [Involvement of the fundus oculi in our Behçet patients]. Bull Soc
Ophtalmol Fr. 1985 Mar;85(3):317, 320.

363: Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, Serdaroğlu
S, Ersanli M, Ulkü BY, Müftüoğlu AU. Influence of age of onset and patient's sex
on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum
Dis. 1984 Dec;43(6):783-9.

364: Ozdoğan H, Yazici H. The efficacy of local steroid injections in idiopathic
carpal tunnel syndrome: a double-blind study. Br J Rheumatol. 1984
Nov;23(4):272-5.

365: Dixon JS, Yurdakul S, Surrall KE, Yazici H, Chamberlain MA. A study of serum
biochemistry in Behçet's syndrome. Br J Rheumatol. 1984 Nov;23(4):283-7.

366: Yazici H, Chamberlain MA, Tüzün Y, Yurdakul S, Müftüoglu A. A comparative
study of the pathergy reaction among Turkish and British patients with Behçet's
disease. Ann Rheum Dis. 1984 Feb;43(1):74-5.

367: Yazici H, Chamberlain MA, Schreuder GM, Bird-Stewart J, Denman M. HLA B5 and
Behçet's disease. Ann Rheum Dis. 1983 Oct;42(5):602-3.

368: Yurdakul S, Yazici H, Tüzün Y, Pazarli H, Yalçin B, Altaç M, Ozyazgan Y,
Tüzüner N, Müftüoğlu A. The arthritis of Behçet's disease: a prospective study.
Ann Rheum Dis. 1983 Oct;42(5):505-15.

369: Yazici H, Bilge N, Kinay M. Total lymphoid irradiation for psoriatic
arthritis: case report. Arthritis Rheum. 1983 Aug;26(8):1052.

370: Dundar SV, Yazici H. Superior vena cava syndrome. Mayo Clin Proc. 1982
Dec;57(12):785.

371: Yazici H, Pazarli H. Eye involvement in a patient with familial
Mediterranean fever. J Rheumatol. 1982 Jul-Aug;9(4):644.

372: Altaç M, Tüzün Y, Yurdakul S, Binyildiz P, Yazici H. The validity of the
pathergy test (non-specific skin hyperreactivity) in Behçet's disease: a
double-blind study by independent observers. Acta Derm Venereol.
1982;62(2):158-9.

373: Yazici H, Tuzlaci M, Yurdakul S. A controlled survey of sacroiliitis in
Behcet's disease. Ann Rheum Dis. 1981 Dec;40(6):558-9.

374: Ozyazgan Y, Pazarli H, Yazici H, Yurdakul S, Tüzün Y, Altaç M, Ulkü B,
Müftüoğlu A. Usefulness of HLA determination and pathergy test in the diagnosis
of uveitis in Turkey. Br J Ophthalmol. 1981 Nov;65(11):798-9.

375: Yurdakul S, Yazici H, Tüzüner N, Aytac S, Müftüoğlu AU. Olecranon nodules in
a case of Behçet's disease. Ann Rheum Dis. 1981 Apr;40(2):182-4.

376: Yazici H, Tüzüner N, Tüzün Y, Yurdakul S. Localized myositis in Behçet's
disease. Arthritis Rheum. 1981 Apr;24(4):636.

377: Tüzün Y, Yazici H. A method of measuring skin lesions. Arch Dermatol. 1981
Apr;117(4):192.

378: Müftüoğlu AU, Yazici H, Yurdakul S, Pazarli H, Ozyazgan Y, Tüzün Y, Altaç M,
Yalçin B. Behçet's disease: lack of correlation of clinical manifestations with
HLA antigens. Tissue Antigens. 1981 Feb;17(2):226-30.

379: Yazici H, Chamberlain MA, Schreuder I, D'Amaro J, Muftuoglu M. HLA antigens
in Behçet's disease: a reappraisal by a comparative study of Turkish and British
patients. Ann Rheum Dis. 1980 Aug;39(4):344-8.

380: Minkari T, Pars B, Erbengi T, Yalçin B, Aytaç S, Yurdakul S, Canberk Y,
Müftüoglu AU. A case of Whipple's disease complicated by fatal hepatitis.
Hepatogastroenterology. 1980 Aug;27(4):322-6.

381: Binak K, Ucak D, Yalcin B, Tavsanoglu S, Aytac S, Yurdakul S, Muftuoglu A.
Left ventricular aneurysm and acute pericarditis in a case of Behcet's disease. J
Rheumatol. 1980 Jul-Aug;7(4):578-80.

382: Aktulga E, Altaç M, Müftüoglu A, Ozyazgan Y, Pazarli H, Tüzün Y, Yalçin B,
Yazici H, Yurdakul S. A double blind study of colchicine in Behçet's disease.
Haematologica. 1980 Jun;65(3):399-402.

383: Tüzün Y, Altaç M, Yazici H, Basöz A, Yurdakul S, Pazarli H, Yalçin B,
Müftüoglu A. Nonspecific skin hyperreactivity in Behçet's disease. Haematologica.
1980 Jun;65(3):395-8.

384: Yalçin B, Gürsoy A, Ezer G, Pazarli H, Tüzün Y, Yuradakul S, Yazici H,
Müftüoglu A. Haematological and immunological features of Behçet's disease.
Haematologica. 1980 Jun;65(3):390-4.

385: Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Yalçin B, Müftüoglu A. Behçet's
disease as seen in Turkey. Haematologica. 1980 Jun;65(3):381-3.

386: Yazici H, Tuzun Y, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The
combined use of HLA-B5 and the pathergy test as diagnostic markers of Behçet's
disease in Turkey. J Rheumatol. 1980 Mar-Apr;7(2):206-10.

387: Tüzün Y, Yazici H, Pazarli H, Yalçin B, Yurdakul S, Müftüoğlu A. The
usefulness of the nonspecific skin hyperreactivity (the pathergy test) in
Behçet's disease in Turkey. Acta Derm Venereol. 1979;59(1):77-9.

388: Yazici H, Akokan G, Yalçin B, Müftüoğlu A. The high prevalence of HLA-B5 in
Behçet's disease. Clin Exp Immunol. 1977 Nov;30(2):259-61.

389: Yazici H. Letter: Management of multiple myeloma. N Engl J Med. 1976 Apr
1;294(14):787-8.

390: Yazici H, Singer K, Lundberg WV. Alcohol and ventricular arrhythmia. Ann
Intern Med. 1973 Jan;78(1):153.

391: Yazici H, Saville PD, Salvati EA, Bohne WH, Wilson PD Jr. Primary
osteoarthrosis of the knee or hip. Prevalence of Heberden nodes in relation to
age and sex. JAMA. 1975 Mar 24;231(12):1256-60.